secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zymeworks Inc. (ZYME)
CIK:        0001937653
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0001193125-24-192058
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zymeworks enters ATM sales agreement with TD Cowen for at-the-market stock offerings
--------------------------------------------------------------------------------

- Agreement dated August 2, 2024 with TD Securities (USA) LLC (TD Cowen) as sales agent.
- Shares offered via methods permitted under Rule 415(a)(4), including on Nasdaq.
- Commission of up to 3.0% of gross proceeds on any shares sold under the agreement.
- Company is not obligated to sell any shares and may terminate agreement at any time.
- Offered under existing S-3ASR registration statement filed May 2, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937653/000119312524192058/0001193125-24-192058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937653/000119312524192058/d842353d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-192058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer